The Gill Medical Centre
Salford, Greater Manchester, M28 3DR, United Kingdom
NCT Number: NCT04970394
Cervical cancer screening is offered to all women in the United Kingdom (UK) between the ages of 24.5 and 64 years of age. The majority of screening is performed in primary care and the rate remains stubbornly below 80%, despite an automated national invitation system. This study is designed to assess the effectiveness of a physician invitation during a telephone or face-to-face primary care appointment upon non responders of automated invitations, to increase the uptake of cervical screening.
Looking for future studies?
Notify Me25 year–65 year
Female
Observational
Salford, Greater Manchester, M28 3DR, United Kingdom
It is estimated that between 800 and 2,000 deaths a year are now prevented due to the effectiveness of the UK's national cervical screening programme and mortality rates have dropped by over 75% since the 1970s. These statistics corroborate the importance of the screening programme in reducing mortality from cervical cancer. Cervical screening rates in the UK remains stubbornly below 80% and interventions are needed to attract the 20% who are missing out on screening. This prospective observational study is designed to measure the impact of a physician intervention in a usual healthcare environment, amongst a heterogeneous patient population to yield replicable real-world results. The intervention arm will receive a physician intervention to inform them of their overdue screening status, remind them of the importance of cervical screening and guide them to book a screening appointment. The screening rate in the intervention arm will be compared to a control made up of patients seen by other clinicians and receiving unstructured reminders. The results will assist physicians in deciding whether a structured intervention is anymore effective than the unstructured advice currently given at improving screening rates in the non responder population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Verbal reminder and if seen face-to-face, a written appointment booking slip.
Time frame: Up to 1 year post intervention
The number of patients who undergo cervical screening
Time frame: Up to 1 year post intervention
Length of time taken to undergo screening following intervention
Dr. Faizan Awan
Other
Three-year Prospective Cohort Study of the Effectiveness of Physician Reminders on Cervical Screening Uptake Amongst Non Responders in a UK Primary Care Setting
Acronym: VRCS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03749707
Cervical Cancer, Female Urogenital Diseases
Aarhus, Denmark
View Trial DetailsNCT05783167
Blood-Borne Infections, Cervical Cancer
Bissau, Guinea-Bissau
View Trial DetailsNCT04679675
Cervical Cancer, Cervical Dysplasia
Seattle, Washington, United States
View Trial DetailsNCT05996796
Cervical Cancer, Cervical Intraepithelial Neoplasia
Edegem, Antwerp, Belgium
View Trial Details